Tiotropium vs long‐acting beta‐agonists
Cost‐effectiveness · patients with stable chronic obstructive pulmonary disease and > 10 pack years smoking history
1 finding from 1 review
- Tiotropium versus long‐acting beta‐agonists for stable chronic obstructive pulmonary disease 2012 · Cochrane Headline outcomes onlyno estimate extracted6 participantsLow